Gustave-Roussy est un centre régional de lutte contre le cancer situé à Villejuif dans le Val-de-Marne en France. Il était auparavant connu sous le nom d’institut Gustave-Roussy ou IGR.

During the past decade, Institut Gustave Roussy - DITEP conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Gustave Roussy - DITEP" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institut Gustave Roussy - DITEP" are "Adenocarcinoma" (1 trials), "Antineoplastic Agents" (1 trials), "Bronchial Neoplasms" (1 trials), "Carcinoma" (1 trials) and "Carcinoma, Bronchogenic" (1 trials). Many other conditions were trialed in "Institut Gustave Roussy - DITEP" in a lesser frequency.

Most popular intervention types in "Institut Gustave Roussy - DITEP" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BLU-945" (1 trials), "Bevacizumab" (1 trials), "Nivolumab" (1 trials), "Oxaliplatin" (1 trials) and "Trifluridine/tipiracil hydrochloride (S 95005)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Gustave Roussy - DITEP" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institut Gustave Roussy - DITEP". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut Gustave Roussy - DITEP, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Gustave Roussy - DITEP, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".